Q32 Bio Inc.

General ticker "QTTB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $35.6M (TTM average)

Q32 Bio Inc. follows the US Stock Market performance with the rate: 32.9%.

Estimated limits based on current volatility of 5.5%: low 5.51$, high 6.15$

Factors to consider:

  • Total employees count: 124 as of 2018
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.03$, 5.84$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.96$, 5.46$]

Financial Metrics affecting the QTTB estimates:

  • Positive: with PPE of 2.3 at the end of fiscal year the price was low
  • Negative: Operating cash flow per share per price, % of -87.57 <= 0.02
  • Positive: Operating profit margin, % of 31.45 > 18.38
  • Positive: Return on assets ratio (scaled to [-100,100]) of 32.56 > 6.07
  • Positive: Investing cash flow per share per price, % of 18.27 > -0.63
  • Negative: negative Industry operating cash flow (median)
  • Positive: Shareholder equity ratio, % of 68.01 > 64.15

Similar symbols

Short-term QTTB quotes

Long-term QTTB plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $53.74MM
Operating Expenses $48.26MM $66.10MM $36.84MM
Operating Income $-48.26MM $-66.10MM $16.90MM
Non-Operating Income $-5.17MM $20.02MM $12.92MM
R&D Expense $31.73MM $48.14MM $19.16MM
Income(Loss) $-53.42MM $-46.09MM $29.82MM
Taxes $0.32MM $0.02MM $0.00MM
Other Income(Loss) $0.00MM $-1.62MM $0.00MM
Profit(Loss)* $-53.74MM $-47.73MM $29.82MM
Stockholders Equity $72.99MM $5.67MM $42.01MM
Assets $84.56MM $92.33MM $61.78MM
Operating Cash Flow $-18.68MM $-67.72MM $-33.54MM
Capital expenditure $0.01MM $0.07MM $0.00MM
Investing Cash Flow $-0.01MM $19.93MM $7.00MM
Financing Cash Flow $0.41MM $95.14MM $-3.12MM
Earnings Per Share** $-16.70 $-3.91 $2.42

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.